PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia (October 2017)
Actelion-Verkauf - Jean-Paul und Martine Clozel: Das 30-Milliarden-Paar
Jean-Paul Clozel – mit Herzblut für Actelion - Rendez-vous - SRF
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
Big Boss - Jean-Paul Clozel | TV5MONDE Europe
Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges
Actelion CEO and founder Jean-Paul Clozel attends a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann Photo Stock - Alamy
How is Actelion Spin-Off Idorsia Doing One Year Later?
Jean-Paul Clozel | EY - Global
Actelion wins FDA approval for hypertension drug - San Francisco Business Times
Startup Guide - Jean-Paul and Martine Clozel are... | Facebook
Jean-Paul Clozel
Was plant das Ehepaar Clozel? | NZZ
We could be the 1st EU-Biopharma entering the Major League"
Jean-Paul Clozel, co-founder of Actelion Ltd., speaks during a news... News Photo - Getty Images
Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma
Swiss biotech group Actelion CEO Jean-Paul Clozel arrives for his company's annual general meeting in Basel, May 5, 2011. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS HEALTH Stock Photo - Alamy
Actelion Chief Executive Officer Jean-Paul Clozel poses at the Forbes... News Photo - Getty Images
Jean-Paul Clozel, CEO Actelion - YouTube
Profile: Jean-Paul Clozel | Nature Biotechnology
Actelion hi-res stock photography and images - Alamy
Jean-Paul Clozel, patron de l'entreprise de biotechnologie Actelion - RTS.ch
Actelion - Wikipedia
Jean-Paul Clozel: «Idorsia steht nicht zum Verkauf» | Finanz und Wirtschaft
Jean-Paul Clozel
Molecular Millionaire: Jean-Paul Clozel of Actelion
J&J seals $30bn Swiss Actelion deal | The Peninsula Qatar
Actelion: independent thinking | Financial Times
